Jennifer Glennon
Keine laufenden Positionen mehr
Profil
Jennifer Glennon worked as Head-Global Research & Development Business at LEO Pharma.
A from 2012 to 2015.
Prior to that, she was the Chief Financial Officer at Nordic Biotech Advisors ApS from 2008 to 2011.
From 2015 to 2018, she worked as Vice President-Finance & Operations at Evelo Biosciences, Inc. Ms. Glennon completed her undergraduate degree at INSEAD.
Ehemalige bekannte Positionen von Jennifer Glennon
| Unternehmen | Position | Ende |
|---|---|---|
| EVELO BIOSCIENCES, INC. | Geschäftsführer | 01.11.2018 |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Corporate Officer/Principal | 01.01.2015 |
Nordic Biotech Advisors ApS
 Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Finanzdirektor/CFO | 30.11.2011 |
Ausbildung von Jennifer Glennon
| INSEAD | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| EVELO BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Nordic Biotech Advisors ApS
Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Finance |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
